[Residency educators may use the following slides on Adolescent Vaccines for their own teaching purposes.] CDC’s Primary Care and Public Health Initiative.

Slides:



Advertisements
Similar presentations
2010 National Immunization Survey Report, Texas Child and Teen Vaccination Coverage Levels Jack Sims-Immunization Branch Manager Tony Aragon, MS-Epidemiologist.
Advertisements

Changes to Regulation 645 under the Immunization of School Pupils Act Additional Protection for Children Attending School in Ontario Coming July 1, 2014.
Meningococcemia: Epidemiology & Prevention Baylor College of Medicine Med-Peds Continuity Clinic Anoop Agrawal, M.D.
Pertussis Disease Pertussis (‘whooping cough’) is a bacterial infection affecting the respiratory system, caused by the organism Bordetella pertussis.
PROTECTING BABIES THROUGH IMMUNIZATION SAFE AND HEALTHY BABIES.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
ACIP Meeting Update November 4 th
Adolescent Vaccines What every parent needs to know!
Pediatric Immunizations Update and Controversies Diane Dooley MD March 27, 2009.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
School Based Immunization Campaign
Tricia Washburn Rhode Island Department of Health Chief, Office of Immunization Rhode Island School Immunization Regulations.
HPV Vaccine.
Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.
Adult Immunization 2010 Meningococcal Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.
Adult Immunization 2010 Herpes Zoster (Shingles) Segment This material is in the public domain This information is valid as of May 25, 2010.
Case Study: Jennifer and James Amy B. Middleman, MD, MSEd, MPH Assistant Professor, Department of Pediatrics, Adolescent Medicine Section, Baylor College.
What's New on the Child and Adolescent Immunization Schedules William L. Atkinson, MD, MPH National Center for Immunization and Respiratory Diseases William.
Childhood Immunization Update for WIC and Clerical Personnel Presented by: Date:
Jeff Neccuzi, Director Division of Immunization Services WV Bureau for Public Health.
1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.
Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.
Developed By: Barbara (Bobbi) P. Clarke, PhD. RD Professor & Extension Health Specialist, Co-Director for The University of Tennessee Center for Community.
TM 2011 Immunization Recommendations H. Cody Meissner, M.D. Professor of Pediatrics Tufts University School of Medicine Boston Floating Hospital for Children.
TM Prepared for your next patient. Review of Selected Changes to the 2012 Immunization Schedules H. Cody Meissner, MD Floating Hospital for Children Tufts.
IMMUNIZATION (1) “ Discuss the population health benefits of immunization programs ” Probability of contracting communicable disease depends on probability.
Immunizations: 101 The Basics of Vaccine Administration
1 Universal Immunization Against Rare Diseases  How much is a child’s life worth?  The individual vs society.
ADOLESCENT IMMUNIZATIONS
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 68 Childhood Immunization.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 31 Health Supervision.
HPV Related Disease Ginny Ryan. What Is HPV? The human papillomavirus is the most common sexually transmitted infection in the U.S. – 79 million Americans.
Pertussis and Adolescents: It’s Time for a Boost A Slide Kit for School Nurses.
5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees
Better Health. No Hassles. Get Immunized! National Immunization Month.
Vaccination of Adolescents: New Frontiers Andrew Kroger National Center for Immunization and Respiratory Diseases National Assembly on School- based Health.
MENINGOCOCCAL PNEUMOCOCCAL TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone starting at 6 mos old y/o.
Tetanus and Tetanus Toxoid Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.
BCG Vaccine Usual reactions induration: 2 – 4 wks pustule formation: 5 – 7 wks scar formation: 2 – 3 months Accelerated Reactions: induration: 2-3 days.
Efficacy of immunization among HIV infected adults: An Observation R Bansal, N Gupta Crosslay AIDS & Wellness Centre Pushpanjali Crosslay Hospital Vaishali.
Presentation Outline Introduction Reasons to Immunize Adults: Make the Case Myths vs. Facts Barriers to Adult Immunization The Ask Adult Immunization Resources.
MENINGOCOCCAL POLYSACCHARIDE PNEUMOCOCCAL POLYSACCHARIDE TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone.
Troi Cunningham, RN Kentucky Immunization Program October 2015.
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Meningococcal Disease and Meningococcal Vaccines
Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at
HPV and Pap Guidelines Jennifer Johnson MD. Objectives 1. Define the new PAP guidelines. 2. Identify the historical trends and new evidence resulting.
Job Corps Webinar: Immunizations John Kulig MD MPH Lead Medical Specialist September 29 & 30, 2010.
Date of download: 6/21/2016 From: Recommended Adult Immunization Schedule: United States, October 2007–September 2008(1) Ann Intern Med. 2007;147(10):
Date of download: 6/22/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Notes: aHepatitis B vaccine (HepB). AT BIRTH: All newborns should.
Vaccination Recommendations Sepehr Khashaei Assistant Professor of Internal Medicine.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory.
Adult Immunizations August 23, 2004 Vinod Kurup, MD
The Impact of Vaccines: Personal Stories Women in Government Learning Exchange on Adult Vaccine Policies August 1, 2017 Diane C Peterson Immunization.
Adolescent Immunization Trivia
Adolescent Immunization Trivia
You are the Key to HPV Cancer Prevention
© I.M.Quizitor Pediatrics Date.
Human Papillomavirus Kenneth McCall, BSPharm, PharmD, BCGP
10 Things You Should Know About HPV
Immunization Update 2007 Tdap Vaccine Segment
2010 Tennessee Immunization Requirements for School Entrance:
What’s New with Vaccines
What’s New in Adult Immunization
Immunization FaQs 2018 Amy Bachyrycz.
10 Things You Should Know About HPV
Adolescent Immunization Trivia
Chapter 27 Pediatrics.
Adolescent and Adult ACIP Update
Presentation transcript:

[Residency educators may use the following slides on Adolescent Vaccines for their own teaching purposes.] CDC’s Primary Care and Public Health Initiative August 22, 2012 Adolescent Vaccines

Objectives  Describe diseases prevented by adolescent immunization  Review current recommendations for each of the adolescent vaccines  Review issues related to vaccinating adolescents, such as strategies and safety  Increase learner understanding of the process of immunization

2012 Recommended Immunization Schedule for Persons Aged 7 Through 18 Years

Four Vaccines Are Recommended for ALL Preteens at age 11 or 12 years  Tetanus-diphtheria-acellular pertussis vaccine (Tdap)  Meningococcal conjugate vaccine (MCV4)  Human papillomavirus vaccine (HPV)  Influenza (flu) vaccine

Catch-Up Vaccines Recommended for Adolescents  Polio  Hepatitis B  MMR  Varicella  Hepatitis A

Vaccines Recommended for Adolescents with High-Risk Conditions  Pneumococcal conjugate vaccine (PCV13)  Pneumococcal polysaccharide vaccine (PPSV23)

Immunization Process  Assess the patient’s immunization history  Check the recommended immunization schedule  Screen for contraindications and precautions  Educate the parent and patient  Administer all needed vaccines  Document administered vaccines  Inform parents and patients when vaccines are needed next

Assess the Immunization History  Assess for needed vaccines at EVERY health care visit  Acute and health promotion visits  Sources for immunization history include  Medical record (current and previous health care providers)  Immunization Information System  Patient immunization record card  School immunization records  Physicians should only accept documented vaccine doses  Patients without documentation should be started on the age-appropriate vaccination schedule

Check the Immunization Schedule  Updated and published annually in the Morbidity and Mortality Weekly Report (MMWR)  Assess using the correct schedule, based on the patient's age  Available in print and electronic formats at  A free app is available for iPhone, Android, and Palm Pre (WebOS) phones

PERTUSSIS (WHOOPING COUGH) AND Tdap VACCINE

Pertussis Among Adolescents and Adults  Prolonged cough (3 months or longer)  Vomiting after prolonged coughing  Weight loss  Multiple medical visits and extensive medical evaluations  Loss of sleep  Transmission to infants

Pertussis Among Adolescents and Adults  Complications (pneumonia, rib fractures)  Hospitalization  Missed school and work  Impact on public health system

Why Do Adolescents Need Pertussis Vaccine?  Pertussis is endemic in the United States  Outbreaks are still occurring  Protection provided by the DTaP vaccine series wanes, so adolescents need Tdap as a booster  Increasing Tdap immunization rates among adolescents is an important strategy for reducing pertussis among adolescents and infants too young to be fully immunized

Tdap Recommendations for Adolescents  Preteens at age 11 or 12 years  Teens aged 13 through 18 years who did not receive Tdap at age 11 or 12 years MMWR 2011;60(1):13–5

Tdap Recommendations for Adolescents  Tdap should be administered regardless of interval since the last tetanus or diphtheria toxoid-containing vaccine  Tdap vaccine can be administered at the same time as other adolescent vaccines

MENINGITIS (NEISSERIA MENINGITIDIS) AND MENINGOCOCCAL CONJUGATE VACCINE (MCV4)

Meningococcal Disease New England Journal of Medicine 2001;344:1372

Meningococcal Disease Incidence by Age CDC Emerging Infections Programs cases 2000–2009 projected to the U.S. population

Neisseria meningitidis Risk Factors for Invasive Disease  Immunodeficient persons (e.g., no spleen)  HIV infection  Family members of an infected person  Smoking  Passive exposure to smoke  Upper respiratory tract infection  Crowding  College students (living in dormitory)

MCV4 Recommendations for Adolescents  Two doses of MCV4 are recommended for adolescents aged 11 through 18 years:  First dose at age 11 or 12 years  Booster dose at age 16 years  Adolescents who receive their first dose of MCV4 at or after age 16 years do not need a booster dose

Adolescents with Certain Medical Conditions  Two-dose primary series in adolescents with  HIV infection  Asplenia  Complement component deficiency

HUMAN PAPILLOMAVIRUS (HPV) AND HPV VACCINE

Human Papillomavirus (HPV)  More than 100 types  Established cause of cervical and other anogenital cancers (anal, penile cancer)  Worldwide cervical cancer causes 233,000 deaths per year  Genital warts

Human Papillomavirus (HPV)  Most common sexually transmitted pathogen in males and females  6.2 million new infections in US annually  20 million people infected  Highest prevalence in sexually active adolescents and young adults  First infection occurs soon after onset of sexual activity

Percentage of Adolescents Who Have Had Vaginal Sex, By Gender and Age National Survey of Family Growth, Mosher et al., 2005; Vital and Health Statistics: No. 362

HPV Vaccine Recommendations for Adolescents  Two HPV vaccines are licensed in the US  Vaccination with either bivalent or quadrivalent HPV vaccine is recommended for GIRLS aged 11 or 12 years  Vaccination with quadrivalent HPV vaccine is recommended for BOYS aged 11 or 12 years  HPV vaccines administered in 3 doses  Use the same brand of HPV vaccine for the entire series

HPV Vaccine Recommendations for Adolescents  Also for females aged 13 through 26 years who did not get any or all of the doses when they were younger  Also for males aged 13 through 21 years who did not get any or all of the three recommended doses when they were younger  For MSM, catch-up should continue through age 26 years

HPV Vaccine: Special Situations  Vaccine can still be given, even if  History of genital warts  History of abnormal Pap test result  Patient is immunocompromised  Female patient is breastfeeding

INFLUENZA DISEASE AND INFLUENZA (FLU) VACCINE

Influenza  Flu can be serious, even for healthy adolescents  Adolescents with high-risk conditions more likely to suffer flu complications  Flu seasons are unpredictable and can be severe

Influenza Vaccine Recomendations  Adolescents should receive a single dose of influenza vaccine every year  Two types of flu vaccine available for adolescents:  Injection: Trivalent Inactivated Influenza Vaccine (TIV)  Intranasal: Live, Attenuated Influenza Vaccine (LAIV)  Be aware of vaccine precautions and contraindications

Screen for Contraindications and Precautions  Key to preventing serious adverse reactions following vaccination is screening  Ask screening questions every time vaccines are needed  Follow only true contraindications and precautions

Vaccine Contraindications and Precautions  Contraindication  Severe allergic reaction to a vaccine component or following a prior dose  Encephalopathy not due to another identifiable cause occurring within 7 days of a pertussis-containing vaccine For pertussis-containing vaccines only  Precaution  Moderate or severe acute illnesses (defer until symptoms improve)

Contraindications and Precautions Condition Pregnancy Immunosuppression Moderate-severe illness Recent blood product Influenza high risk groups Condition Pregnancy Immunosuppression Moderate-severe illness Recent blood product Influenza high risk groupsLiveCCP P** P** C*** C***LiveCCP P** P** C*** C***InactivatedV*VPVVInactivatedV*VPVV C=contraindication P=precaution V=vaccinate if indicated * Except HPV. **MMR and varicella-containing (except zoster vaccine) ***LAIV only C=contraindication P=precaution V=vaccinate if indicated * Except HPV. **MMR and varicella-containing (except zoster vaccine) ***LAIV only

Educate the Parent and Patient  Immunization education should include:  Benefits of and risks associated with the vaccines  After care instructions for managing side effects  Use Vaccine Information Statements (VIS)  Give EVERY time a dose of vaccine is administered  Available in print and electronic formats from CDC at

Administer All Needed Vaccines  Ensure vaccines are prepared and administered correctly  Tdap, MCV4, and HPV vaccines can be administered during the same health care visit  And influenza vaccine during flu season  Administer any vaccines that may have been missed earlier in childhood

General Adolescent Vaccine Safety  Fainting—or syncope—can occur after any medical procedure, including vaccination  Adolescents should be seated or lying down during vaccination  Providers should consider observing patients in seated or lying positions for 15 minutes after vaccination  Concern: risk for serious secondary injuries  Vaccine Adverse Event Reporting System

Document Administered Vaccines  Document immunizations in the medical record and an Immunization Information System  Federal law requires all immunization providers to document:  Date vaccine dose given  Date Vaccine Information Statement (VIS) given  Date on VIS  Vaccine manufacturer  Vaccine lot number  Signature of person administering the vaccine  Best practice: record type of vaccine, site, dosage, and route

Inform Parents and Patients when Vaccines are Needed Next  Utilize tracking, reminder, and recall systems  Reminder/recall: let parents and adolescents know a vaccine or dose is due or missed IIS or registries often can help with reminder/recall  Standing orders  Schedule an appointment for the next dose before leaving the facility

Considerations for Providing Vaccines to Adolescents  Use all visits as opportunities for immunization  Check vaccination status at each visit  Compliance with 3-dose regimen  Provider recommendation is strongest predictor of vaccination

Physicians Can Change Minds National Immunization Survey interviews in 2003–2004 suggested that 1. 28% of parents were doubtful about benefits and safety of certain vaccines 2. Parents who were doubtful delayed or refused child's vaccination Most parents who changed their minds about delaying or refusing vaccination cited information from their physician as the main reason for the change. Journal of Pediatrics, October 2008

Stay Up to Date  Visit accurate websites:  CDC  American Academy of Pediatrics and  American Academy of Family Physicians  Immunization Action Coalition  Sign up for alerts, listservs if possible  Subscribe to CDC’s MMWR  Find additional resources from your state or local health department immunization program

Summary  Adolescents continue to be adversely affected by vaccine-preventable diseases  Recommend vaccines to your patients and their parents  Use preventive and acute care visits to ensure adolescents receive all needed vaccines  Integrate proven strategies to improve vaccination rates into health care systems

CDC Vaccines and Immunization Contact Information  Telephone 800.CDC.INFO (for patients and parents)  (for providers)  Website  Vaccine Safety /

Thank You!